The role of insulin/IGF-1 signaling pathways in maintaining a differentiated phenotype of pancreatic islet β-cells and the development of obesity-associated DM II is discussed. The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.